In this Issue:
Indigenous Australian women’s inequalities in cervical screening
Safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced HPV-associated cancers
Bevacizumab vs bevacizumab + fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma
Physical inactivity and mortality in women with invasive EOC
Menopausal oestrogen-only therapy and ovarian carcinoma risk
Uterine cancer after RRSO without hysterectomy in women with BRCA mutations
Germline BRCA1/2 mutation testing is indicated in every patient with EOC
Primary surgery vs neoadjuvant chemotherapy in advanced EOC
Histologic pattern and the management of uterine carcinosarcoma
Clinico-pathological features, molecular subtypes and treatment outcome in serous ovarian and primary peritoneal cancers
Patient outcomes with mismatch repair-deficient, high-stage ovarian clear cell carcinoma
Please login below to download this issue (PDF)